News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Gray Cameron
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/16/2022 |
4
| Gray Cameron (Director) has filed a Form 4 on Cue Biopharma, Inc.|
Txns:
| Paid exercise price by delivering 51,562 shares
@ $3.2, valued at
$165k
Exercised (in-or-at-the-money) 61,111 warrants
@ $2.7, valued at
$165k
|
|
| 01/05/2022 |
4
| Gray Cameron (Director) has filed a Form 4 on Cue Biopharma, Inc.|
Txns:
| Granted 10,000 options to buy
@ $12.28, valued at
$122.8k
|
|
| 01/06/2021 |
4
| Gray Cameron (Director) has filed a Form 4 on Cue Biopharma, Inc.|
Txns:
| Granted 10,000 options to buy
@ $12.36, valued at
$123.6k
|
|
| 10/01/2020 |
4
| Gray Cameron (Director) has filed a Form 4 on Cue Biopharma, Inc.|
Txns:
| Bought 5,000 shares
@ $15, valued at
$75k
Bought 5,000 shares
@ $15.3, valued at
$76.5k
|
|
| 01/06/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/28/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/03/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/19/2018 |
4
| Gray Cameron (Director) has filed a Form 4 on Provention Bio, Inc.|
Txns:
| Granted 128,981 options to buy
@ $4, valued at
$515.9k
Converted 144,824 options to buy
@ $2.5, valued at
$362.1k
|
|
| 06/14/2018 |
4
| Gray Cameron (Director) has filed a Form 4 on Cue Biopharma, Inc.|
Txns:
| Exercised 8,000 options to buy
@ $14.24, valued at
$113.9k
|
|
|
|